Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between estimated time with low glomerular filtration rate and access to transplant among youth with advanced chronic kidney disease.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Bilateral Glomerulocystic Kidney Disease With Extensive Embryonal Hyperplasia in a Setting of <i>HNF1B</i> Mutation.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same author

Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis.

PloS one·2025
Same author

Sequence of antihypertensive medications used in preterm infants with hypertension: A cross-sectional study.

PloS one·2025
Same author

Sugar, salt, immunity and the cause of primary hypertension.

Clinical kidney journal·2023
Same author

Adverse childhood experiences are associated with vascular changes in adolescents that are risk factors for future cardiovascular disease.

Pediatric nephrology (Berlin, Germany)·2023
Same journal

The Physician Leader: Teaching Leadership in Medicine.

Advances in chronic kidney disease·2022
Same journal

Postgraduate Education and Training for the Nephrology Physician Assistants and Nurse Practitioners.

Advances in chronic kidney disease·2022
Same journal

Evaluation Evolution: Designing Optimal Evaluations to Enhance Learning in Nephrology Fellowship.

Advances in chronic kidney disease·2022
Same journal

Kidney Pathology Education for Nephrology Fellows: Past, Present, and Future.

Advances in chronic kidney disease·2022
Same journal

Clinician Educator Pathway for Nephrology Fellows: The University of North Carolina Experience.

Advances in chronic kidney disease·2022
Same journal

Current Trends and Challenges in Nephrology Fellowship Training: Expansion of Education in Home Dialysis, Palliative Care, and Point-of-Care Ultrasound.

Advances in chronic kidney disease·2022
See all related articles

Related Experiment Video

Updated: May 17, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Hyperuricemia and hypertension.

Daniel I Feig1

  • 1Division of Nephrology, Department of Pediatrics, University of Alabama, Birmingham, AL 35233, USA. dfeig@peds.uab.edu

Advances in Chronic Kidney Disease
|October 24, 2012
PubMed
Summary
This summary is machine-generated.

High uric acid levels may cause hypertension through a two-phase process. Lowering uric acid shows promise in reducing blood pressure, especially in early-onset hypertension.

Related Experiment Videos

Last Updated: May 17, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Uric acid has been historically linked to hypertension and cardiovascular disease.
  • Recent research provides mechanistic insights into this association.
  • Hyperuricemia is increasingly recognized as a potential contributor to cardiovascular risk.

Purpose of the Study:

  • To elucidate the mechanistic link between uric acid and hypertension.
  • To investigate the role of uric acid in the development of hypertension.
  • To evaluate the impact of reducing uric acid levels on blood pressure.

Main Methods:

  • Utilized animal models to explore a two-phase mechanism of hyperuricemic hypertension.
  • Examined the role of the renin-angiotensin system in acute uric acid-induced vasoconstriction.
  • Conducted small clinical trials in adolescents with essential hypertension.

Main Results:

  • Animal models revealed a two-phase mechanism: acute vasoconstriction followed by vascular smooth muscle cell proliferation.
  • Acute hypertension was uric acid-dependent and sodium-independent.
  • Chronic hypertension became uric acid-independent and sodium-dependent.
  • Reducing serum uric acid levels lowered blood pressure in hypertensive adolescents.

Conclusions:

  • Uric acid plays a likely causative role in some instances of early-onset hypertension.
  • A two-phase mechanism involving vasoconstriction and arteriolosclerosis contributes to hyperuricemic hypertension.
  • Therapeutic reduction of uric acid may be a viable strategy for managing certain types of hypertension.